Enlivex Therapeutics (ENLV)
(Delayed Data from NSDQ)
$1.47 USD
+0.11 (8.09%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $1.48 +0.01 (0.68%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 33% (82 out of 250)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | -0.25 | -2.04 | 57.00 |
Year Ago Quarter Estimate | -0.39 | -0.59 | 52.54 |
Next Quarter Estimate | -0.24 | -2.00 | 61.00 |
Next Year Estimate | -0.55 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 44.87 | 14.20 | 15.67 |
Next Year | 36.05 | 14.60 | 9.31 |
Last 5 Years | -329.00 | 6.90 | 8.10 |
Next 5 Years | NA | 24.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 0.84 | 1.93 |
Price/Cash Flow (MRFY) | NA | 8.45 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -67.62% |
Return on Equity (TTM) | -71.00% | -59.74% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.